245 related articles for article (PubMed ID: 20351605)
21. Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications.
Kim HJ; Hagan M; Butman JA; Baggenstos M; Brewer C; Zalewski C; Linehan WM; Lonser RR
Laryngoscope; 2013 Feb; 123(2):477-83. PubMed ID: 23070752
[TBL] [Abstract][Full Text] [Related]
22. Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in von Hippel-Lindau disease.
Jagannathan J; Lonser RR; Stanger RA; Butman JA; Vortmeyer AO; Zalewski CK; Brewer C; Surowicz C; Kim HJ
Otol Neurotol; 2007 Oct; 28(7):927-30. PubMed ID: 17468670
[TBL] [Abstract][Full Text] [Related]
23. Isolate vertigo crisis revealing an endolymphatic sac tumor.
Codreanu C; Tran Ba Huy P
Rom J Morphol Embryol; 2010; 51(2):387-9. PubMed ID: 20495761
[TBL] [Abstract][Full Text] [Related]
24. Endolymphatic sac tumors: experience of three cases.
Bastier PL; de Mones E; Marro M; Elkhatib W; Franco-Vidal V; Liguoro D; Darrouzet V
Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1551-7. PubMed ID: 23212692
[TBL] [Abstract][Full Text] [Related]
25. The Gruppo Otologico experience of endolymphatic sac tumor.
Husseini ST; Piccirillo E; Taibah A; Paties CT; Almutair T; Sanna M
Auris Nasus Larynx; 2013 Feb; 40(1):25-31. PubMed ID: 22326122
[TBL] [Abstract][Full Text] [Related]
26. "Endolymphatic sac tumour": A case report with review of literature.
Rajeshwari B; Shanmugam S; Sadiya N; Mitra G; Chendilnathan B
Indian J Pathol Microbiol; 2019; 62(4):608-610. PubMed ID: 31611452
[TBL] [Abstract][Full Text] [Related]
27. Coexpression of erythropoietin and its receptor in endolymphatic sac tumors.
Vogel TW; Vortmeyer AO; Lubensky IA; Lee YS; Furuta M; Ikejiri B; Kim HJ; Lonser RR; Oldfield EH; Zhuang Z
J Neurosurg; 2005 Aug; 103(2):284-8. PubMed ID: 16175858
[TBL] [Abstract][Full Text] [Related]
28. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
[TBL] [Abstract][Full Text] [Related]
29. Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment.
Kim HJ; Butman JA; Brewer C; Zalewski C; Vortmeyer AO; Glenn G; Oldfield EH; Lonser RR
J Neurosurg; 2005 Mar; 102(3):503-12. PubMed ID: 15796386
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease.
Butman JA; Kim HJ; Baggenstos M; Ammerman JM; Dambrosia J; Patsalides A; Patronas NJ; Oldfield EH; Lonser RR
JAMA; 2007 Jul; 298(1):41-8. PubMed ID: 17609489
[TBL] [Abstract][Full Text] [Related]
31. Symptoms and clinical features in patients affected by endolymphatic sac tumor: a systematic review and meta-analysis.
Gioacchini FM; Kaleci S; Chiarella G; Viola P; Pisani D; Scarpa A; Tulli M; Pace A; Iannella G; Re M
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5081-5088. PubMed ID: 35704074
[TBL] [Abstract][Full Text] [Related]
32. The vestibular aqueduct: site of origin of endolymphatic sac tumors.
Lonser RR; Baggenstos M; Kim HJ; Butman JA; Vortmeyer AO
J Neurosurg; 2008 Apr; 108(4):751-6. PubMed ID: 18377255
[TBL] [Abstract][Full Text] [Related]
33. Endolymphatic sac tumors: clinical outcome and management in a series of 9 cases.
Timmer FC; Neeskens LJ; van den Hoogen FJ; Slootweg PJ; Dunnebier EA; Pauw BK; Mulder JJ; Cremers CW; Kunst HP
Otol Neurotol; 2011 Jun; 32(4):680-5. PubMed ID: 21451430
[TBL] [Abstract][Full Text] [Related]
34. [Tumour staged surgery of endolymphatic sac tumors (ELST)].
Schipper J; Maier W; Rosahl S; Berlis A; Laszig R
Laryngorhinootologie; 2004 Aug; 83(8):493-500. PubMed ID: 15316888
[TBL] [Abstract][Full Text] [Related]
35. Management of von Hippel-Lindau disease-associated CNS lesions.
Wind JJ; Lonser RR
Expert Rev Neurother; 2011 Oct; 11(10):1433-41. PubMed ID: 21955200
[TBL] [Abstract][Full Text] [Related]
36. Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies.
Zanoletti E; Girasoli L; Borsetto D; Opocher G; Mazzoni A; Martini A
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):423-429. PubMed ID: 29165437
[TBL] [Abstract][Full Text] [Related]
37. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls.
Jester R; Znoyko I; Garnovskaya M; Rozier JN; Kegl R; Patel S; Tran T; Abedalthagafi M; Horbinski CM; Richardson M; Wolff DJ; Lapadat R; Moore W; Rodriguez FJ; Mull J; Olar A
Acta Neuropathol Commun; 2018 Oct; 6(1):107. PubMed ID: 30340515
[TBL] [Abstract][Full Text] [Related]
38. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
Vortmeyer AO; Choo D; Pack S; Oldfield E; Zhuang Z
Neurology; 2000 Aug; 55(3):460. PubMed ID: 10932304
[No Abstract] [Full Text] [Related]
39. [Endolymphatic sac tumor and von Hippel-Lindau disease. Review of the literature].
de Minteguiaga C; García Ibáñez L; Tran Ba Huy P
Acta Otorrinolaringol Esp; 2002; 53(7):515-20. PubMed ID: 12487074
[TBL] [Abstract][Full Text] [Related]
40. Vestibular Function in Children With Von Hippel-Lindau Disease.
Fatih Turgut N; Crunkhorn R; Iqbal J; Dasgupta S
J Int Adv Otol; 2021 Jul; 17(4):361-367. PubMed ID: 34309559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
